| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 51 | 2024 | 1666 | 4.930 |
Why?
|
| Ventricular Remodeling | 15 | 2024 | 1264 | 2.420 |
Why?
|
| Physical Conditioning, Animal | 7 | 2022 | 365 | 2.100 |
Why?
|
| Heart | 21 | 2024 | 4391 | 2.000 |
Why?
|
| Exercise | 13 | 2024 | 5874 | 1.860 |
Why?
|
| Cardiomegaly | 15 | 2024 | 591 | 1.750 |
Why?
|
| Heart Failure | 23 | 2024 | 11653 | 1.620 |
Why?
|
| Myocardium | 24 | 2024 | 4700 | 1.600 |
Why?
|
| Myocardial Reperfusion Injury | 9 | 2024 | 480 | 1.590 |
Why?
|
| MicroRNAs | 14 | 2024 | 3796 | 1.540 |
Why?
|
| Activins | 3 | 2024 | 210 | 1.140 |
Why?
|
| Immediate-Early Proteins | 4 | 2017 | 449 | 1.090 |
Why?
|
| Heart Diseases | 4 | 2024 | 2785 | 1.060 |
Why?
|
| Aging | 12 | 2020 | 8689 | 0.960 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2011 | 2453 | 0.950 |
Why?
|
| Signal Transduction | 32 | 2020 | 23397 | 0.880 |
Why?
|
| Boidae | 1 | 2022 | 14 | 0.830 |
Why?
|
| Neovascularization, Physiologic | 9 | 2013 | 1339 | 0.810 |
Why?
|
| Apoptosis | 23 | 2024 | 9468 | 0.770 |
Why?
|
| Animals | 111 | 2024 | 168253 | 0.750 |
Why?
|
| Oxygenases | 9 | 2001 | 59 | 0.750 |
Why?
|
| Myostatin | 4 | 2009 | 128 | 0.720 |
Why?
|
| Phosphatidylinositol 3-Kinases | 8 | 2014 | 2860 | 0.710 |
Why?
|
| Mice | 67 | 2024 | 81402 | 0.630 |
Why?
|
| Activin Receptors, Type II | 1 | 2019 | 123 | 0.620 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2022 | 241 | 0.610 |
Why?
|
| Stroke Volume | 8 | 2023 | 5487 | 0.580 |
Why?
|
| Reperfusion Injury | 4 | 2024 | 1023 | 0.570 |
Why?
|
| Metabolic Diseases | 1 | 2024 | 681 | 0.570 |
Why?
|
| Fatty Liver | 2 | 2022 | 782 | 0.560 |
Why?
|
| Regeneration | 2 | 2018 | 1508 | 0.550 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2005 | 4509 | 0.540 |
Why?
|
| Echocardiography, Doppler | 1 | 2020 | 898 | 0.530 |
Why?
|
| Disease Models, Animal | 22 | 2024 | 18216 | 0.520 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2020 | 850 | 0.510 |
Why?
|
| Mice, Knockout | 22 | 2022 | 14397 | 0.500 |
Why?
|
| Myocardial Infarction | 15 | 2023 | 11453 | 0.490 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 1957 | 0.490 |
Why?
|
| Mitochondria, Heart | 5 | 2016 | 229 | 0.490 |
Why?
|
| Annexin A5 | 3 | 2009 | 103 | 0.480 |
Why?
|
| Pre-Eclampsia | 1 | 2024 | 1229 | 0.470 |
Why?
|
| Endothelium, Vascular | 8 | 2013 | 4430 | 0.440 |
Why?
|
| Transcription Factors | 12 | 2024 | 12121 | 0.440 |
Why?
|
| Cardiovascular Diseases | 8 | 2024 | 15476 | 0.440 |
Why?
|
| Rats | 25 | 2020 | 23712 | 0.430 |
Why?
|
| Carbocyanines | 3 | 2009 | 175 | 0.430 |
Why?
|
| Cardiovascular System | 2 | 2017 | 835 | 0.420 |
Why?
|
| Hypertrophy | 6 | 2017 | 559 | 0.400 |
Why?
|
| Cells, Cultured | 28 | 2020 | 18955 | 0.400 |
Why?
|
| Models, Cardiovascular | 4 | 2015 | 985 | 0.390 |
Why?
|
| Osteopontin | 1 | 2013 | 301 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 24 | 2022 | 22121 | 0.390 |
Why?
|
| Ketone Bodies | 2 | 2021 | 76 | 0.390 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3407 | 0.380 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2009 | 1929 | 0.380 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2011 | 62 | 0.380 |
Why?
|
| Nitroso Compounds | 1 | 2011 | 71 | 0.380 |
Why?
|
| I-kappa B Kinase | 2 | 2011 | 250 | 0.380 |
Why?
|
| Gene Expression Regulation | 13 | 2020 | 11900 | 0.380 |
Why?
|
| Methylococcaceae | 3 | 1997 | 4 | 0.370 |
Why?
|
| Romano-Ward Syndrome | 1 | 2010 | 3 | 0.370 |
Why?
|
| Nitrites | 1 | 2011 | 159 | 0.370 |
Why?
|
| Cell Transplantation | 1 | 2012 | 472 | 0.360 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 835 | 0.360 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2013 | 819 | 0.340 |
Why?
|
| Ventricular Function, Left | 3 | 2020 | 3876 | 0.330 |
Why?
|
| Genetic Vectors | 7 | 2024 | 3392 | 0.320 |
Why?
|
| Enzyme Activation | 6 | 2011 | 3592 | 0.310 |
Why?
|
| Myocardial Ischemia | 6 | 2017 | 2110 | 0.310 |
Why?
|
| Cytokines | 3 | 2023 | 7377 | 0.310 |
Why?
|
| Nitric Oxide | 4 | 2012 | 2133 | 0.300 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 2248 | 0.280 |
Why?
|
| Adenoviridae | 10 | 2005 | 1084 | 0.280 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2009 | 540 | 0.270 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2009 | 262 | 0.270 |
Why?
|
| Fibrosis | 6 | 2020 | 2048 | 0.270 |
Why?
|
| Carrier Proteins | 4 | 2005 | 4936 | 0.260 |
Why?
|
| Humans | 76 | 2024 | 760437 | 0.260 |
Why?
|
| Animals, Newborn | 8 | 2017 | 2676 | 0.250 |
Why?
|
| Ribonucleotide Reductases | 2 | 2001 | 76 | 0.240 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2018 | 2117 | 0.230 |
Why?
|
| Cell Hypoxia | 5 | 2011 | 656 | 0.230 |
Why?
|
| Endothelial Cells | 6 | 2016 | 3541 | 0.230 |
Why?
|
| Genes, erbB-2 | 1 | 2004 | 162 | 0.230 |
Why?
|
| Gene Deletion | 3 | 2022 | 2667 | 0.230 |
Why?
|
| Transgenes | 4 | 2008 | 1009 | 0.230 |
Why?
|
| Dietary Proteins | 1 | 2009 | 953 | 0.230 |
Why?
|
| Stem Cells | 4 | 2009 | 3522 | 0.230 |
Why?
|
| Membrane Glycoproteins | 2 | 2024 | 3701 | 0.220 |
Why?
|
| Mice, Transgenic | 13 | 2017 | 9533 | 0.220 |
Why?
|
| Contrast Media | 5 | 2018 | 5310 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 2693 | 0.220 |
Why?
|
| Blotting, Western | 7 | 2017 | 5031 | 0.210 |
Why?
|
| Cell Proliferation | 8 | 2018 | 10425 | 0.210 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1886 | 0.210 |
Why?
|
| Peripartum Period | 1 | 2024 | 137 | 0.210 |
Why?
|
| NF-kappa B | 4 | 2013 | 2485 | 0.210 |
Why?
|
| Cell Survival | 9 | 2017 | 5790 | 0.210 |
Why?
|
| Stem Cell Transplantation | 2 | 2012 | 1598 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 1959 | 0.210 |
Why?
|
| Cell Division | 4 | 2006 | 4461 | 0.200 |
Why?
|
| Dependovirus | 2 | 2024 | 715 | 0.200 |
Why?
|
| Ischemia | 6 | 2011 | 1876 | 0.200 |
Why?
|
| Gene Transfer Techniques | 3 | 2004 | 1205 | 0.200 |
Why?
|
| Crystallography, X-Ray | 10 | 2001 | 1982 | 0.200 |
Why?
|
| Coronary Disease | 2 | 2007 | 5919 | 0.200 |
Why?
|
| Bone Marrow Cells | 3 | 2011 | 2416 | 0.190 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2020 | 2058 | 0.190 |
Why?
|
| Cardiac Resynchronization Therapy | 3 | 2018 | 553 | 0.190 |
Why?
|
| Models, Animal | 2 | 2022 | 2111 | 0.190 |
Why?
|
| Asparagine | 1 | 2001 | 119 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 3631 | 0.190 |
Why?
|
| Protein Interaction Mapping | 2 | 2017 | 616 | 0.190 |
Why?
|
| Streptomyces | 1 | 2001 | 91 | 0.190 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 128 | 0.180 |
Why?
|
| Iron | 6 | 2001 | 1787 | 0.180 |
Why?
|
| Rodentia | 1 | 2022 | 261 | 0.180 |
Why?
|
| Amidohydrolases | 1 | 2001 | 162 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2014 | 4355 | 0.180 |
Why?
|
| Eye Proteins | 1 | 2024 | 633 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2017 | 2895 | 0.170 |
Why?
|
| Heart Ventricles | 6 | 2019 | 3815 | 0.170 |
Why?
|
| Phenylephrine | 3 | 2006 | 293 | 0.170 |
Why?
|
| Regional Blood Flow | 2 | 2011 | 1487 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2016 | 240 | 0.170 |
Why?
|
| Receptors, LDL | 1 | 2022 | 490 | 0.170 |
Why?
|
| Necrosis | 4 | 2013 | 1604 | 0.170 |
Why?
|
| Copper | 2 | 1999 | 368 | 0.170 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2010 | 102 | 0.170 |
Why?
|
| Male | 42 | 2024 | 360035 | 0.170 |
Why?
|
| Phenotype | 8 | 2020 | 16585 | 0.170 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2009 | 409 | 0.170 |
Why?
|
| Gene Targeting | 1 | 2003 | 838 | 0.170 |
Why?
|
| Zebrafish | 4 | 2022 | 3002 | 0.170 |
Why?
|
| Caspase 3 | 3 | 2009 | 729 | 0.170 |
Why?
|
| Phosphorylation | 7 | 2013 | 8311 | 0.160 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2009 | 609 | 0.160 |
Why?
|
| Molecular Chaperones | 2 | 2005 | 755 | 0.160 |
Why?
|
| Inflammation | 4 | 2022 | 10746 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2013 | 2870 | 0.160 |
Why?
|
| Follistatin-Related Proteins | 1 | 2019 | 48 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 1857 | 0.160 |
Why?
|
| Echocardiography | 5 | 2018 | 4981 | 0.160 |
Why?
|
| Cholesterol | 2 | 2022 | 2902 | 0.150 |
Why?
|
| Lipopolysaccharides | 2 | 2006 | 2205 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2022 | 787 | 0.150 |
Why?
|
| Glucose | 3 | 2023 | 4342 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4567 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 12127 | 0.150 |
Why?
|
| Protein Kinases | 1 | 2005 | 1607 | 0.150 |
Why?
|
| Protein Structure, Secondary | 4 | 2001 | 1230 | 0.150 |
Why?
|
| Ligands | 4 | 2019 | 3270 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1314 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2002 | 3777 | 0.140 |
Why?
|
| Mammals | 1 | 2022 | 1132 | 0.140 |
Why?
|
| Muscle Proteins | 3 | 2015 | 1152 | 0.140 |
Why?
|
| Enzyme Induction | 3 | 2014 | 451 | 0.140 |
Why?
|
| Caspases | 3 | 2005 | 876 | 0.140 |
Why?
|
| Constriction, Pathologic | 2 | 2019 | 1097 | 0.140 |
Why?
|
| Enalapril | 1 | 2018 | 313 | 0.140 |
Why?
|
| Superoxide Dismutase | 1 | 1999 | 592 | 0.140 |
Why?
|
| Pressure | 2 | 2019 | 1155 | 0.140 |
Why?
|
| Systole | 1 | 2019 | 937 | 0.140 |
Why?
|
| Ureteral Obstruction | 1 | 2018 | 293 | 0.140 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 203 | 0.140 |
Why?
|
| Heart Failure, Systolic | 1 | 2018 | 135 | 0.130 |
Why?
|
| Cell Cycle Proteins | 5 | 2016 | 3446 | 0.130 |
Why?
|
| S100 Proteins | 1 | 2016 | 218 | 0.130 |
Why?
|
| Muscle Development | 1 | 2017 | 259 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2819 | 0.130 |
Why?
|
| Diastole | 1 | 2018 | 782 | 0.120 |
Why?
|
| Cell Enlargement | 1 | 2015 | 60 | 0.120 |
Why?
|
| Granulocyte-Macrophage Progenitor Cells | 2 | 2011 | 21 | 0.120 |
Why?
|
| Monocytes | 2 | 2018 | 2572 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 340 | 0.120 |
Why?
|
| Blood Proteins | 1 | 2020 | 1174 | 0.120 |
Why?
|
| Placenta | 1 | 2024 | 1704 | 0.120 |
Why?
|
| High Mobility Group Proteins | 2 | 2014 | 177 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 2413 | 0.120 |
Why?
|
| Fish Oils | 1 | 2018 | 481 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2014 | 102 | 0.120 |
Why?
|
| Potassium Channels | 2 | 2010 | 537 | 0.120 |
Why?
|
| Microscopy, Confocal | 3 | 2017 | 1967 | 0.120 |
Why?
|
| Sodium Channel Blockers | 2 | 2012 | 174 | 0.120 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2011 | 113 | 0.120 |
Why?
|
| Genome, Human | 1 | 2007 | 4423 | 0.120 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2006 | 177 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 4 | 2013 | 2642 | 0.110 |
Why?
|
| Receptor, erbB-2 | 1 | 2004 | 2553 | 0.110 |
Why?
|
| Methane | 1 | 1993 | 51 | 0.110 |
Why?
|
| Sirtuin 2 | 1 | 2014 | 95 | 0.110 |
Why?
|
| Culture Media, Serum-Free | 2 | 2005 | 148 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 1807 | 0.110 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 9598 | 0.110 |
Why?
|
| I-kappa B Proteins | 2 | 2005 | 211 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 2224 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 5794 | 0.110 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2015 | 145 | 0.110 |
Why?
|
| Lipodystrophy | 1 | 2014 | 148 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2018 | 36362 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1999 | 1841 | 0.110 |
Why?
|
| Models, Molecular | 8 | 2010 | 5427 | 0.110 |
Why?
|
| Sirtuin 3 | 2 | 2010 | 67 | 0.110 |
Why?
|
| Cell Communication | 1 | 2020 | 1652 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2005 | 1745 | 0.100 |
Why?
|
| Transfection | 5 | 2016 | 5776 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2012 | 53 | 0.100 |
Why?
|
| Trans-Activators | 3 | 2008 | 2858 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2020 | 4106 | 0.100 |
Why?
|
| RNA, Messenger | 5 | 2014 | 12785 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2012 | 1974 | 0.100 |
Why?
|
| Protein Conformation | 3 | 2010 | 3969 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2016 | 8163 | 0.100 |
Why?
|
| Insulin | 4 | 2009 | 6591 | 0.100 |
Why?
|
| Consensus Sequence | 1 | 2012 | 365 | 0.100 |
Why?
|
| DNA, Complementary | 4 | 2004 | 1992 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2006 | 579 | 0.100 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 11070 | 0.100 |
Why?
|
| Angiogenic Proteins | 1 | 2012 | 101 | 0.100 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2011 | 31 | 0.100 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 365 | 0.090 |
Why?
|
| Autophagy | 2 | 2017 | 1319 | 0.090 |
Why?
|
| Mixed Function Oxygenases | 1 | 1992 | 266 | 0.090 |
Why?
|
| Ventricular Myosins | 1 | 2011 | 49 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2016 | 733 | 0.090 |
Why?
|
| Acetanilides | 1 | 2012 | 169 | 0.090 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2011 | 28 | 0.090 |
Why?
|
| Amino Acid Sequence | 7 | 2010 | 13445 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 687 | 0.090 |
Why?
|
| Cytosol | 2 | 2005 | 888 | 0.090 |
Why?
|
| Cyclophilins | 1 | 2010 | 47 | 0.090 |
Why?
|
| Gene Expression Profiling | 4 | 2016 | 9410 | 0.090 |
Why?
|
| Sodium | 2 | 2022 | 1589 | 0.090 |
Why?
|
| Molecular Biology | 1 | 2014 | 580 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2008 | 193 | 0.090 |
Why?
|
| Up-Regulation | 4 | 2018 | 4116 | 0.090 |
Why?
|
| Molecular Sequence Data | 8 | 2010 | 17639 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2013 | 305 | 0.090 |
Why?
|
| Oxidation-Reduction | 4 | 2021 | 2227 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2687 | 0.090 |
Why?
|
| Immunoblotting | 2 | 2005 | 1647 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2012 | 435 | 0.090 |
Why?
|
| Gadolinium DTPA | 2 | 2013 | 823 | 0.090 |
Why?
|
| Physical Fitness | 1 | 2014 | 739 | 0.090 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2011 | 199 | 0.090 |
Why?
|
| Binding Sites | 6 | 2001 | 6042 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 704 | 0.090 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2009 | 21 | 0.090 |
Why?
|
| Annexins | 1 | 2009 | 38 | 0.090 |
Why?
|
| Pregnancy | 3 | 2024 | 29831 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 7597 | 0.080 |
Why?
|
| Protein Subunits | 2 | 2004 | 942 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2009 | 553 | 0.080 |
Why?
|
| Macrophages | 3 | 2018 | 5764 | 0.080 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2010 | 158 | 0.080 |
Why?
|
| Pentetic Acid | 1 | 2009 | 209 | 0.080 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2009 | 240 | 0.080 |
Why?
|
| Cell Line | 6 | 2011 | 15598 | 0.080 |
Why?
|
| Electrocardiography | 3 | 2012 | 6380 | 0.080 |
Why?
|
| Piperazines | 2 | 2012 | 2519 | 0.080 |
Why?
|
| Nanotechnology | 3 | 2009 | 712 | 0.080 |
Why?
|
| Stress, Mechanical | 2 | 2005 | 1674 | 0.080 |
Why?
|
| Mitochondria | 3 | 2014 | 3624 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2009 | 63 | 0.080 |
Why?
|
| Female | 22 | 2024 | 391875 | 0.080 |
Why?
|
| Proteomics | 2 | 2020 | 3818 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3609 | 0.080 |
Why?
|
| Age Factors | 3 | 2016 | 18379 | 0.080 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 5126 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 502 | 0.080 |
Why?
|
| Myofibrils | 1 | 2009 | 141 | 0.080 |
Why?
|
| Hypertension | 6 | 2018 | 8527 | 0.080 |
Why?
|
| Proteins | 1 | 2003 | 6033 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 762 | 0.080 |
Why?
|
| Energy Transfer | 1 | 2008 | 108 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1404 | 0.080 |
Why?
|
| NAD | 2 | 2014 | 614 | 0.080 |
Why?
|
| Hydroxylation | 3 | 2001 | 137 | 0.080 |
Why?
|
| Thyroid Hormones | 1 | 2011 | 404 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2016 | 2929 | 0.070 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 499 | 0.070 |
Why?
|
| Heart Failure, Diastolic | 1 | 2008 | 76 | 0.070 |
Why?
|
| Perfusion | 3 | 2012 | 1374 | 0.070 |
Why?
|
| Adiponectin | 2 | 2014 | 1113 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15867 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2011 | 613 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 9176 | 0.070 |
Why?
|
| Cell Nucleus | 3 | 2007 | 2906 | 0.070 |
Why?
|
| Phosphoproteins | 3 | 2005 | 2444 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 427 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2006 | 512 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2011 | 544 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 617 | 0.070 |
Why?
|
| Risk Factors | 6 | 2024 | 74055 | 0.070 |
Why?
|
| Time Factors | 10 | 2016 | 39947 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2015 | 11526 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 2852 | 0.070 |
Why?
|
| Liver | 1 | 2022 | 7531 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2016 | 3486 | 0.070 |
Why?
|
| Oxidative Stress | 3 | 2017 | 3108 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2011 | 698 | 0.070 |
Why?
|
| Spin Labels | 1 | 2008 | 338 | 0.070 |
Why?
|
| Heart Injuries | 1 | 2008 | 205 | 0.070 |
Why?
|
| Longevity | 1 | 2014 | 1062 | 0.070 |
Why?
|
| Factor XIII Deficiency | 1 | 2006 | 16 | 0.070 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2006 | 48 | 0.070 |
Why?
|
| Tomography, Optical | 1 | 2007 | 129 | 0.070 |
Why?
|
| Bone Development | 1 | 2009 | 472 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2001 | 2749 | 0.070 |
Why?
|
| Catalysis | 3 | 2001 | 774 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2009 | 6230 | 0.070 |
Why?
|
| Action Potentials | 2 | 2010 | 1830 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2023 | 1989 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 649 | 0.060 |
Why?
|
| Myosin Heavy Chains | 2 | 2011 | 404 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 983 | 0.060 |
Why?
|
| Antibodies | 1 | 2013 | 2421 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2006 | 191 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17854 | 0.060 |
Why?
|
| Hexokinase | 1 | 2005 | 125 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2005 | 186 | 0.060 |
Why?
|
| Biotransformation | 1 | 2005 | 166 | 0.060 |
Why?
|
| Flow Cytometry | 4 | 2009 | 5865 | 0.060 |
Why?
|
| Homeostasis | 2 | 2018 | 3320 | 0.060 |
Why?
|
| Glycogen | 1 | 2005 | 251 | 0.060 |
Why?
|
| Magnetics | 1 | 2008 | 599 | 0.060 |
Why?
|
| Deoxyglucose | 1 | 2005 | 333 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2002 | 203 | 0.060 |
Why?
|
| Fungal Proteins | 2 | 1999 | 910 | 0.060 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2005 | 76 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 293 | 0.060 |
Why?
|
| Escherichia coli | 3 | 2001 | 4234 | 0.060 |
Why?
|
| Cell Movement | 3 | 2013 | 5198 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 389 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 237 | 0.060 |
Why?
|
| Co-Repressor Proteins | 1 | 2005 | 191 | 0.060 |
Why?
|
| Muscle, Skeletal | 7 | 2011 | 4923 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 5778 | 0.060 |
Why?
|
| Aged | 10 | 2020 | 168840 | 0.060 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2005 | 196 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2241 | 0.060 |
Why?
|
| Cell Fractionation | 1 | 2004 | 251 | 0.060 |
Why?
|
| Diabetic Angiopathies | 1 | 2009 | 804 | 0.060 |
Why?
|
| Cell Count | 2 | 2005 | 1834 | 0.060 |
Why?
|
| Hydrogen Bonding | 2 | 2001 | 291 | 0.060 |
Why?
|
| Methylococcus capsulatus | 2 | 2001 | 8 | 0.060 |
Why?
|
| Myosin Light Chains | 1 | 2004 | 121 | 0.060 |
Why?
|
| Thyroid Gland | 1 | 2011 | 1168 | 0.060 |
Why?
|
| Adult | 10 | 2024 | 220781 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 1444 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 1693 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15820 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2012 | 1304 | 0.060 |
Why?
|
| Fasting | 2 | 2007 | 1600 | 0.050 |
Why?
|
| Tibia | 1 | 2009 | 1069 | 0.050 |
Why?
|
| Myocarditis | 1 | 2011 | 770 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 2010 | 3075 | 0.050 |
Why?
|
| Androstadienes | 1 | 2005 | 348 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2009 | 649 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 658 | 0.050 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1736 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2004 | 410 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 3396 | 0.050 |
Why?
|
| Kinetics | 3 | 2009 | 6377 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2008 | 1113 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2011 | 1355 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7424 | 0.050 |
Why?
|
| Phospholipases A | 1 | 2003 | 204 | 0.050 |
Why?
|
| Insulin Resistance | 2 | 2014 | 3956 | 0.050 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2002 | 27 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2002 | 68 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2002 | 691 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 877 | 0.050 |
Why?
|
| RNA, Complementary | 1 | 2002 | 45 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2005 | 862 | 0.050 |
Why?
|
| X-Ray Diffraction | 2 | 1993 | 420 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 435 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2008 | 1565 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 1636 | 0.050 |
Why?
|
| Multipotent Stem Cells | 1 | 2004 | 200 | 0.050 |
Why?
|
| Organ Size | 3 | 2018 | 2252 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 28 | 0.050 |
Why?
|
| Thymidine | 1 | 2022 | 299 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2003 | 169 | 0.050 |
Why?
|
| Catalytic Domain | 2 | 2001 | 705 | 0.050 |
Why?
|
| Ketones | 1 | 2023 | 183 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2002 | 185 | 0.050 |
Why?
|
| Risk | 2 | 2020 | 9605 | 0.050 |
Why?
|
| Clavulanic Acid | 1 | 2001 | 19 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 188 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2002 | 189 | 0.050 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2001 | 18 | 0.050 |
Why?
|
| Flavonoids | 1 | 2005 | 444 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2003 | 302 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 901 | 0.050 |
Why?
|
| Hydrocarbons, Iodinated | 1 | 2001 | 8 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 686 | 0.050 |
Why?
|
| Cell Size | 2 | 2013 | 624 | 0.050 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2001 | 29 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 589 | 0.050 |
Why?
|
| Cell Adhesion | 3 | 2004 | 3088 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2003 | 276 | 0.050 |
Why?
|
| Calcineurin | 1 | 2022 | 229 | 0.050 |
Why?
|
| Alkanes | 1 | 2001 | 41 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2003 | 366 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2010 | 2571 | 0.050 |
Why?
|
| Cell Membrane | 3 | 2005 | 3685 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1055 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2003 | 476 | 0.050 |
Why?
|
| Static Electricity | 1 | 2001 | 261 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 906 | 0.050 |
Why?
|
| Xenon | 1 | 2001 | 112 | 0.050 |
Why?
|
| Cell Death | 2 | 2006 | 1664 | 0.050 |
Why?
|
| Nanoparticles | 2 | 2009 | 1953 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 548 | 0.050 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2003 | 378 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 489 | 0.050 |
Why?
|
| DNA | 3 | 2012 | 7208 | 0.040 |
Why?
|
| Genotype | 2 | 2013 | 12976 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5662 | 0.040 |
Why?
|
| Middle Aged | 11 | 2024 | 220382 | 0.040 |
Why?
|
| Leucine | 2 | 2002 | 548 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2001 | 2180 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 891 | 0.040 |
Why?
|
| E-Selectin | 1 | 2002 | 576 | 0.040 |
Why?
|
| Gene Expression | 3 | 2011 | 7582 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2060 | 0.040 |
Why?
|
| Hindlimb | 2 | 2011 | 509 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2047 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2003 | 620 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2017 | 64591 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58859 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2009 | 2566 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2005 | 840 | 0.040 |
Why?
|
| Metalloproteins | 2 | 2000 | 101 | 0.040 |
Why?
|
| Wound Healing | 2 | 2008 | 2799 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 4369 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 1301 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 1125 | 0.040 |
Why?
|
| Calcium | 3 | 2006 | 5726 | 0.040 |
Why?
|
| Magnesium | 1 | 2001 | 809 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3800 | 0.040 |
Why?
|
| RNA, Small Untranslated | 1 | 2018 | 77 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 6525 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 856 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2001 | 1792 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 1363 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 2788 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2001 | 3792 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 3710 | 0.030 |
Why?
|
| Crystallization | 2 | 2001 | 533 | 0.030 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2016 | 30 | 0.030 |
Why?
|
| Swine | 2 | 2023 | 5915 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 4413 | 0.030 |
Why?
|
| Heart Atria | 1 | 2022 | 1347 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 230 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2000 | 1079 | 0.030 |
Why?
|
| Bone Density | 1 | 2009 | 3549 | 0.030 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2016 | 68 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 3 | 2009 | 2647 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 2011 | 1824 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 10180 | 0.030 |
Why?
|
| Base Sequence | 4 | 2011 | 12449 | 0.030 |
Why?
|
| Temperature | 1 | 2002 | 2228 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2013 | 1528 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2975 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 428 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2009 | 6380 | 0.030 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2014 | 37 | 0.030 |
Why?
|
| Histones | 1 | 2005 | 2577 | 0.030 |
Why?
|
| Endosomes | 1 | 2017 | 520 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2006 | 3024 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 29551 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2014 | 92 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2002 | 1612 | 0.030 |
Why?
|
| RNA Interference | 2 | 2016 | 2832 | 0.030 |
Why?
|
| Leukocytes | 1 | 2002 | 2024 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2020 | 8479 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2009 | 1759 | 0.030 |
Why?
|
| Rats, Nude | 1 | 2013 | 105 | 0.030 |
Why?
|
| Histidine | 1 | 1994 | 308 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 910 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2014 | 135 | 0.030 |
Why?
|
| Progesterone | 1 | 2017 | 742 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 1751 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2024 | 3049 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2013 | 260 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2163 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 282 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 370 | 0.030 |
Why?
|
| Vascular System Injuries | 1 | 2016 | 246 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 1891 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 20078 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 5491 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1176 | 0.030 |
Why?
|
| Body Water | 1 | 2013 | 340 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2017 | 1134 | 0.030 |
Why?
|
| Mutation | 6 | 2010 | 30025 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 2104 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2015 | 483 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1517 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2018 | 10075 | 0.020 |
Why?
|
| Genomics | 1 | 2007 | 5806 | 0.020 |
Why?
|
| Cardiology | 1 | 2002 | 1668 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1993 | 412 | 0.020 |
Why?
|
| Mitochondrial Swelling | 1 | 2010 | 16 | 0.020 |
Why?
|
| Ligation | 1 | 2012 | 448 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 1435 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 1737 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2014 | 848 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2020 | 2626 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2011 | 211 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2011 | 128 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2875 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3405 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2011 | 249 | 0.020 |
Why?
|
| Dogs | 1 | 2015 | 3839 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 371 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2016 | 1509 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2017 | 1805 | 0.020 |
Why?
|
| Cisplatin | 1 | 1995 | 1647 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2013 | 5966 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2009 | 263 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2011 | 493 | 0.020 |
Why?
|
| Cyclin E | 1 | 2009 | 156 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2006 | 13616 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 491 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2388 | 0.020 |
Why?
|
| Microvessels | 1 | 2013 | 574 | 0.020 |
Why?
|
| Isotopes | 1 | 2008 | 125 | 0.020 |
Why?
|
| Software | 1 | 2002 | 4426 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2009 | 246 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2049 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6086 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2009 | 180 | 0.020 |
Why?
|
| Methyl Methanesulfonate | 1 | 2007 | 28 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2010 | 778 | 0.020 |
Why?
|
| Coronary Sinus | 1 | 2008 | 84 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1054 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3097 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 6475 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2009 | 343 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4277 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2008 | 292 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1739 | 0.020 |
Why?
|
| Food Deprivation | 1 | 2007 | 114 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1340 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2007 | 83 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 903 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 790 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2011 | 834 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2009 | 591 | 0.020 |
Why?
|
| Thyroxine | 1 | 2011 | 668 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 931 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2008 | 348 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 756 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 1900 | 0.020 |
Why?
|
| Mutagens | 1 | 2007 | 179 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 876 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2820 | 0.020 |
Why?
|
| Research Design | 1 | 2002 | 6168 | 0.020 |
Why?
|
| Vibration | 1 | 2008 | 328 | 0.020 |
Why?
|
| Factor XIII | 1 | 2006 | 59 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2006 | 163 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2009 | 1263 | 0.020 |
Why?
|
| Lysine | 1 | 2010 | 992 | 0.020 |
Why?
|
| Endothelium | 1 | 2008 | 765 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2011 | 1241 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 412 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 173 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2011 | 667 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 507 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10188 | 0.020 |
Why?
|
| Adolescent | 2 | 2011 | 88196 | 0.020 |
Why?
|
| Infant | 2 | 2022 | 36183 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3734 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 177 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 2090 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 1004 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 997 | 0.010 |
Why?
|
| Sirtuins | 1 | 2007 | 320 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 575 | 0.010 |
Why?
|
| LLC-PK1 Cells | 1 | 2004 | 125 | 0.010 |
Why?
|
| Ion Channels | 1 | 2009 | 1043 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3510 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 1313 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 84 | 0.010 |
Why?
|
| Nuclear Localization Signals | 1 | 2004 | 77 | 0.010 |
Why?
|
| Weight Gain | 1 | 2014 | 2346 | 0.010 |
Why?
|
| Troponin T | 1 | 2009 | 763 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 2004 | 88 | 0.010 |
Why?
|
| Microcirculation | 1 | 2008 | 1269 | 0.010 |
Why?
|
| Comet Assay | 1 | 2003 | 72 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 2003 | 197 | 0.010 |
Why?
|
| Muramidase | 1 | 2003 | 169 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 664 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 1094 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 319 | 0.010 |
Why?
|
| Adenoviridae Infections | 1 | 2003 | 93 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2009 | 3603 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 359 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2007 | 1511 | 0.010 |
Why?
|
| Epinephrine | 1 | 2006 | 792 | 0.010 |
Why?
|
| Genes, myc | 1 | 2004 | 390 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2006 | 1156 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 1433 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2013 | 4167 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 872 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2009 | 1047 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 236 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 714 | 0.010 |
Why?
|
| Child | 1 | 2010 | 80086 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5236 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 1128 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2006 | 832 | 0.010 |
Why?
|
| Spectroscopy, Mossbauer | 1 | 2001 | 2 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2011 | 2300 | 0.010 |
Why?
|
| Water | 1 | 2008 | 1409 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 427 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2006 | 586 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8611 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 739 | 0.010 |
Why?
|
| Oxygen Isotopes | 1 | 2001 | 43 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 828 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2008 | 1317 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1545 | 0.010 |
Why?
|
| Cyclins | 1 | 2004 | 594 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 979 | 0.010 |
Why?
|
| P-Selectin | 1 | 2004 | 597 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4586 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3590 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 2013 | 2008 | 0.010 |
Why?
|
| Reference Values | 1 | 2008 | 4921 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 12653 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13484 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2012 | 3088 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 20551 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 696 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6388 | 0.010 |
Why?
|
| Benzamides | 1 | 2006 | 1370 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3209 | 0.010 |
Why?
|
| X-Rays | 1 | 2001 | 306 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 6206 | 0.010 |
Why?
|
| Freezing | 1 | 2001 | 310 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12918 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 8967 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1250 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21322 | 0.010 |
Why?
|
| Peripheral Arterial Disease | 1 | 2011 | 1271 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2560 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2008 | 2204 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2003 | 964 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2522 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 1561 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 604 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2001 | 237 | 0.010 |
Why?
|
| Electron Transport | 1 | 2000 | 210 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 2001 | 451 | 0.010 |
Why?
|
| Solubility | 1 | 2001 | 1091 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2004 | 1956 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2003 | 987 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 59068 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 2911 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 745 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1202 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2008 | 2907 | 0.010 |
Why?
|
| Aorta | 1 | 2006 | 2042 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3428 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 4614 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3765 | 0.010 |
Why?
|
| Telomere | 1 | 2004 | 931 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 1164 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 665 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4222 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 3346 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2137 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4063 | 0.010 |
Why?
|
| DNA Adducts | 1 | 1995 | 94 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2002 | 1841 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 2539 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4174 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1994 | 162 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10759 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 3541 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 54339 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2803 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 2911 | 0.010 |
Why?
|
| Neutrophils | 1 | 2006 | 3764 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2423 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14661 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 14002 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1994 | 611 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1995 | 899 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1995 | 1875 | 0.010 |
Why?
|
| Antioxidants | 1 | 1999 | 1670 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 26280 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5105 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 9340 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2001 | 6230 | 0.000 |
Why?
|
| Neoplasms | 1 | 2008 | 22083 | 0.000 |
Why?
|